Coste Catherine bought BLFS
February 24, 2026 · Form 4 insider transaction
Coste Catherine bought 8,170 shares of BioLife Solutions Inc, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,170
Price
N/A
Total value
N/A
InsiderCoste Catherine
RoleDirector
CompanyBioLife Solutions Inc (BLFS)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after13,871
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026.